458 related articles for article (PubMed ID: 33312335)
41. Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells.
Pogue AI; Li YY; Cui JG; Zhao Y; Kruck TP; Percy ME; Tarr MA; Lukiw WJ
J Inorg Biochem; 2009 Nov; 103(11):1591-5. PubMed ID: 19540598
[TBL] [Abstract][Full Text] [Related]
42. microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer.
Nagaraj S; Zoltowska KM; Laskowska-Kaszub K; Wojda U
Ageing Res Rev; 2019 Jan; 49():125-143. PubMed ID: 30391753
[TBL] [Abstract][Full Text] [Related]
43. MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains.
Satoh J
J Pharmacol Sci; 2010; 114(3):269-75. PubMed ID: 20953120
[TBL] [Abstract][Full Text] [Related]
44. Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells.
Zhao Y; Bhattacharjee S; Jones BM; Hill J; Dua P; Lukiw WJ
Mol Neurobiol; 2014 Aug; 50(1):97-106. PubMed ID: 24293102
[TBL] [Abstract][Full Text] [Related]
45. Role of Post-Transcriptional Control of Calpain by miR-124-3p in the Development of Alzheimer's Disease.
Zhou Y; Deng J; Chu X; Zhao Y; Guo Y
J Alzheimers Dis; 2019; 67(2):571-581. PubMed ID: 30584150
[TBL] [Abstract][Full Text] [Related]
46. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
[TBL] [Abstract][Full Text] [Related]
47. Genome-wide identification of microRNA-related variants associated with risk of Alzheimer's disease.
Ghanbari M; Ikram MA; de Looper HWJ; Hofman A; Erkeland SJ; Franco OH; Dehghan A
Sci Rep; 2016 Jun; 6():28387. PubMed ID: 27328823
[TBL] [Abstract][Full Text] [Related]
48. Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.
Butterfield DA; Di Domenico F; Swomley AM; Head E; Perluigi M
Biochem J; 2014 Oct; 463(2):177-89. PubMed ID: 25242166
[TBL] [Abstract][Full Text] [Related]
49. Protective effects of microRNA-330 on amyloid β-protein production, oxidative stress, and mitochondrial dysfunction in Alzheimer's disease by targeting VAV1 via the MAPK signaling pathway.
Zhou Y; Wang ZF; Li W; Hong H; Chen J; Tian Y; Liu ZY
J Cell Biochem; 2018 Jul; 119(7):5437-5448. PubMed ID: 29369410
[TBL] [Abstract][Full Text] [Related]
50. Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β.
Schonrock N; Humphreys DT; Preiss T; Götz J
J Mol Neurosci; 2012 Feb; 46(2):324-35. PubMed ID: 21720722
[TBL] [Abstract][Full Text] [Related]
51. Inflamma-MicroRNAs in Alzheimer's Disease: From Disease Pathogenesis to Therapeutic Potentials.
Liang Y; Wang L
Front Cell Neurosci; 2021; 15():785433. PubMed ID: 34776873
[TBL] [Abstract][Full Text] [Related]
52. Effect of lncRNA WT1-AS regulating WT1 on oxidative stress injury and apoptosis of neurons in Alzheimer's disease via inhibition of the miR-375/SIX4 axis.
Wang Q; Ge X; Zhang J; Chen L
Aging (Albany NY); 2020 Nov; 12(23):23974-23995. PubMed ID: 33234729
[TBL] [Abstract][Full Text] [Related]
53. Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation.
Lv Z; Hu L; Yang Y; Zhang K; Sun Z; Zhang J; Zhang L; Hao Y
Metab Brain Dis; 2018 Oct; 33(5):1711-1720. PubMed ID: 29961914
[TBL] [Abstract][Full Text] [Related]
54. microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease.
Salta E; De Strooper B
FASEB J; 2017 Feb; 31(2):424-433. PubMed ID: 28148775
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA target prediction in glaucoma.
Romano GL; Platania CB; Forte S; Salomone S; Drago F; Bucolo C
Prog Brain Res; 2015; 220():217-40. PubMed ID: 26497793
[TBL] [Abstract][Full Text] [Related]
56. Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.
Lei X; Lei L; Zhang Z; Zhang Z; Cheng Y
Int J Clin Exp Pathol; 2015; 8(2):1565-74. PubMed ID: 25973041
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
Dehghani R; Rahmani F; Rezaei N
Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
[TBL] [Abstract][Full Text] [Related]
58. Alteration of the microRNA network during the progression of Alzheimer's disease.
Lau P; Bossers K; Janky R; Salta E; Frigerio CS; Barbash S; Rothman R; Sierksma AS; Thathiah A; Greenberg D; Papadopoulou AS; Achsel T; Ayoubi T; Soreq H; Verhaagen J; Swaab DF; Aerts S; De Strooper B
EMBO Mol Med; 2013 Oct; 5(10):1613-34. PubMed ID: 24014289
[TBL] [Abstract][Full Text] [Related]
59. Longitudinal Examination of the Intestinal Lamina Propria Cellular Compartment of Simian Immunodeficiency Virus-Infected Rhesus Macaques Provides Broader and Deeper Insights into the Link between Aberrant MicroRNA Expression and Persistent Immune Activation.
Kumar V; Torben W; Kenway CS; Schiro FR; Mohan M
J Virol; 2016 May; 90(10):5003-5019. PubMed ID: 26937033
[TBL] [Abstract][Full Text] [Related]
60. Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro.
Rovčanin Dragović I; Popović N; Ždralević M; Radulović L; Vuković T; Marzano F; Tullo A; Radunović M
J Alzheimers Dis; 2022; 90(2):625-638. PubMed ID: 36155522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
